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Cong P, Pricolo V, Biancani P, Behar J. High levels of caveolar cholesterol inhibit progesterone-induced genomic actions in human and guinea pig gallbladder muscle. Am J Physiol Gastrointest Liver Physiol 296: G948 -G954, 2009. First published February 12, 2009 ; doi:10.1152/ajpgi.90699.2008.-Gallbladder disease is prevalent during pregnancy. It has been suggested that this complication of pregnancy is attributable to increased bile cholesterol (Ch) induced by estrogens and to gallbladder hypomotility caused by increasing levels of progesterone (P4). Studies on nonpregnant gallbladders have shown that increased levels of bile Ch contribute to both gallstone formation and bile stasis. These studies investigated the effects of high levels of plasma membrane Ch on P4 on gallbladder muscle cells from human and guinea pigs. Contraction was studied in intact and permeabilized muscle cells. G proteins were determined by Western blot, and 3 H-P4 incorporation by muscle cells was measured in the ␤-scintillation counter. High levels of caveolar Ch blocked the effects induced by P4 treatment for 6 h. They suppressed the expected P4 inhibition of GTP-␥S (a G protein activator)-induced contraction and changes in G proteins by downregulating Gi3 and upregulating Gs protein levels. Ch inhibited these P4 actions at the caveolar 3 (CAV-3) level, since the P4 effects were antagonized by treatment with CAV-3 antibody, by reducing CAV-3 expression through CAV-3 siRNA. CAV-3 antibody and siRNA reduced caveolar Ch levels. High caveolar levels of Ch and CAV-3 antibody blocked the incorporation of 3 H-P4 into caveolae. Treatment with GDP-␤S (a G protein antagonist) had no effect on P4 actions. High caveolar Ch levels blocked the P4 effects on muscle contraction and G protein changes probably because both Ch and P4 require CAV-3 proteins for their transport across the plasma membrane. muscle cells; caveolar 3 proteins; G proteins THE INCIDENCE OF GALLBLADDER disease associated with supersaturated bile with cholesterol (Ch) and gallstones is high during pregnancy, particularly in the last two trimesters and the immediate postpartum period (2, 14) . It has been suggested that the high incidence of gallstones is caused by increased hepatic secretion of Ch into bile induced by high circulating levels of estrogens (15) and by bile stasis attributable to gallbladder hypomotility caused by the gradual rise in serum progesterone (P4) levels, particularly in the last two trimesters of pregnancy (21) . Previous studies have shown that P4 impairs gallbladder muscle contraction by changing G protein patterns in vivo and in vitro in several animal species (17-20, 25, 28) .
Contraction of the gallbladder is also impaired by abnormal levels of Ch in the plasma membrane that are associated with lithogenic bile supersaturated with Ch (5, 26, 27, 29) . This excessive Ch concentration in the plasma membrane is localized in caveolar membranes that are Ch-rich domains (29) . Activated receptor-G protein complexes internalize into these caveolar domains where they interact with enzymes and second messengers (10 -12) .
High levels of caveolar Ch also appear to increase the content of caveolar 3 (CAV-3) proteins in these domains by inhibiting their phosphorylation induced by the internalized receptor-G protein complex (5, 8) . Furthermore, high levels of CAV-3 sequester receptors that internalize through these rafts disrupting their recycling back to the plasma membrane (8, 29) , thus reducing the number of receptors that bind neurotransmitters and hormones (25) .
P4 has a basic steroid structure similar to that of Ch. However, in contrast to Ch, little is known about how P4 is transported across the plasma membrane. It has been suggested that P4 acts on membrane receptors (13) although it is unknown whether these putative receptors couple to G proteins. Once in the cytosol, P4 binds to heat-shock proteins that act as chaperones transporting them to nuclear receptors A and B to induce various genomic effects (23) .
The molecular similarities between Ch and P4 (a steroidderived hormone) suggest the possibility that P4 may be transported across the plasma membrane, with or without membrane receptors, reaching caveolar domains competing with Ch for access to caveolin proteins. Therefore, present studies were designed to examine whether abnormally high levels of caveolar Ch inhibit the actions of P4 in human and guinea pig gallbladder muscle cells. If that were the case, then the contribution of P4 to the pathogenesis of gallbladder disease during pregnancy might be negligible particularly in the obese because the gallbladder muscle cells are first exposed to lithogenic bile with cholesterol before the rising levels of P4.
MATERIALS AND METHODS
Isolation and permeabilization of muscle cells from human and guinea pig gallbladder. Human muscle cells were obtained mostly from gallbladders with pigment stones because muscle cells from these gallbladders contract normally (1, 3) and have normal levels of Ch in the plasma membrane (5, 29) . The muscle cells were obtained from clinically indicated cholecystectomies, and male guinea pigs (weight 450 -500 g) were purchased from the Charles River Laboratory (Wilmington, MA); the Rhode Island Hospital IRB approved the use of these muscle cells, and the Animal Care Committee of the Rhode Island Hospital approved the protocol used in this study. Previous studies have shown no differences between human and guinea pig gallbladder muscle with respect to their response to Ch and P4 (26, 27) . In both species high levels of caveolar Ch and treatment with P4 impair the contraction, and in both species P4 alters the G protein patterns. Only one set of studies was performed in muscle cells from gallbladder with Ch stones. Human and guinea pig muscle cells were isolated and, in some experiments, permeabilized using methods described previously (5, 27, 29) . The muscle layer was cut into 2-mm-wide strips and digested in HEPES buffer containing 0.5 mg/ml type F collagenase and 2 mg/ml papain (activity of 13.9 U/mg protein) for 20 min at 35°C in a shaking water bath. The buffer was gently gassed with 100% O 2 during the tissue digestion. At the end of the digestive process, the tissue was filtered through Nitex mesh 200 (Tetko, Elmsford, NY) and rinsed with 20 ml HEPES. The tissue remaining on the filter was collected and incubated in HEPES buffer at 35°C for 15 min to allow free dispersion of cells.
For preparation of permeable cells, the partly digested muscle cells were washed with "cytosolic buffer", a medium with the following composition (in mM): 20 NaCl, 100 KCl, 25 NaHCO 3, 0.96 NaH 2PO4, 0.48 CaCl2, 5.0 MgSO4, 1.0 EGTA, pH 7.2, and 2% bovine serum albumin and was maintained by equilibrating with 95% O 2-5% CO 2 at 31°C. The dispersed cells were exposed to saponin (75 g/ml) and then centrifuged at 200 g for 3 min. Cells were washed once with modified cytosolic buffer by centrifugation and suspended again in modified cytosolic buffer and equilibrated at 31°C for 15 min before experiments. The modified cytosolic buffer was prepared with cytosolic buffer plus 1.5 mM ATP, 5 mM creatine phosphate, 10 U/ml of creatine phosphokinase, and 10 M antimycin A.
Muscle cell contraction. Contraction was measured as previously described (5, 24) . It was measured without knowing the type of treatment applied to the cells. Permeable cells were pretreated with buffer (control) or antibodies against CAV-3 proteins (titer 1:400) and fixed in acrolein at 1% final concentration. The cell length was measured with a phase-contrast microscope (Carl Zeiss, Jena, Germany) and a closed circuit television camera (Panasonic, Secaucus, NJ) connected to a Macintosh Computer with NIH Image software. The average length of 30 cells, measured in the absence of agonists, was taken as the control length and compared with length measured after addition of agonists. Shortening was defined as the percent decrease in the average length of 30 cells after treatment with agonists compared with the control length.
siRNA transfection of human muscle strips in organ culture. Organ culture of muscle strips and siRNA transfection were performed using the method described before (7, 22) . Briefly, human gallbladder muscle strips devoid of mucosa and serosa were rinsed several times with sterile Krebs buffer and then placed in serum-and antibiotic-free RPMI 1640 medium containing scramble or CAV-3 siRNA (100 pmol) with lipofectamine 2000 (Invitrogen, Carlsbad, CA) as instructed by the manufacturer. After a 24-h transfection, muscle strips were rinsed in warm PBS and placed into a muscle bath for further studies of tonic contraction as described below. All muscle strips treated with sense and anti-sense siRNA were examined for expression of the target protein by Western blot. Transfection experiments were performed in triplicate.
Transfection efficiency studies. The efficiency of the siRNA transfection was verified with a fluorescent-labeled Oligo (Invitrogen) that was transfected into the muscle strip at the same concentration of the transfection mixture (100 pmol/ml) and vector lipofectamine (7). After 24-h incubation, muscle strips were frozen, and tissue sections (10 M) were placed on slides. The optimal transfection efficiency obtained using an Olympus IX50/FIA fluorescent microscope equipped with a nap-fix camera (Olympus Opticals, Melville, NY) was 65%.
Incorporation of 3 H-P4 into the plasma membrane. Intact or permeabilized gallbladder muscle cells were incubated with 3 H-P4 (specific activity 90 -115 Ci/mmol; New England Nuclear, Boston, MA) at the concentration of 10 Ϫ7 M for 10, 30, and 60 min. The plasma membrane was then subjected to sucrose gradient centrifugation to isolate caveolae and noncaveolar fraction or bulk plasma membrane (plasma membrane plus caveolae). The radioactivity of the caveolar and bulk plasma membrane fractions was determined in the ␤-scintillation counter.
RESULTS
Effect of P4 on muscle cell contraction. CCK-8-induced contraction of dissociated muscle cells from human and guinea pig gallbladder was partially blocked by pretreatment with Ch-rich liposomes for 90 min or after 6-h treatment with P4 (10 Ϫ5 M) compared with the contraction of muscle cells incubated in buffer alone or with Ch-free liposome treatment (Fig. 1) . Treatment with both Ch-rich liposomes and P4 did not further inhibit the CCK-8-induced contraction compared with each individual treatment. In contrast, the GTP-␥S (10 Ϫ7 M)-induced contraction of muscle cells from human and guinea pig gallbladder was not affected by treatment with Ch-rich liposomes, but it was partially blocked by P4 (10 Ϫ5 M) treatment ( Fig. 2A) . More importantly, the P4 inhibition of GTP-␥S-induced contraction was prevented by pretreatment with Ch-rich liposomes for 90 min. Similar findings were obtained when muscle cells from gallbladder with Ch stones were stimulated with GTP-␥S (Fig. 2B) . The contraction was normal in muscle cells incubated with buffer or after treatment with P4 (10 Ϫ5 M) for 6 h. The GTP-␥S-induced contraction, however, was partially blocked by P4 after the muscle cells were incubated with Ch-free liposomes for 90 min to remove the excess Ch from the plasma membrane and caveolar domains (5) .
Effect of high caveolar Ch levels on P4-induced changes in G protein levels. We then examined the actions of high caveolar Ch levels induced by treatment with Ch-rich liposomes on the P4 actions on the expression of G proteins in muscle cells from human and guinea pig gallbladders. In agreement with previous findings (6, 28), P4 (10 Ϫ5 M) treatment for 6 h downregulated Gi3 proteins (Fig. 3A) and upregulated Gs protein expression (Fig. 3B) . The altered expression of these G proteins induced by P4 was blocked in muscle cells pretreated with Ch-rich liposomes for 90 min but was not affected by pretreatment with Ch-free liposomes. Treatment with Ch-rich or -free liposomes by themselves had no effect on the expression of G proteins.
Effect of CAV-3 antibody on P4 effects on muscle contraction and G protein levels. We then examined the site where high levels of Ch could inhibit the actions of P4 in the plasma membrane. Ch is transported across plasma membranes of smooth muscle cells through caveolar domains by interacting with CAV proteins in caveolar domains (10, 11) . It was therefore possible that increases in the levels of caveolar Ch could affect the P4 actions by blocking its internalization across plasma membranes at the level of CAV-3 proteins since P4 and Ch share a similar molecular structure. We thus examined the effect of a specific CAV-3 antibody (Ab) on P4 (10 Ϫ5 M) inhibition of GTP-␥S-induced contraction in permeable muscle cells from guinea pig gallbladder. Pretreatment with CAV-3 Ab (titer 1:800) blocked the expected P4 inhibition of GTP-␥S-induced contraction compared with P4 treatment alone (Fig. 4) . Moreover, treatment with CAV-3 Ab abolished the expected P4-induced changes on G proteins (e.g., downregulation of Gi3 proteins and upregulation of Gs protein expression) (Fig. 5, A and B) .
Effects of CAV-3 siRNA on P4-induced changes in G protein levels.
To further examine whether CAV-3 proteins are the main sites where the high levels of caveolar Ch block the actions of P4, human gallbladder muscle cells were transfected in tissue culture with CAV-3 siRNA or with scramble siRNA (controls) for 24 h. CAV-3 siRNA reduced the CAV-3 protein expression determined by Western blot and blocked the P4 changes in G proteins expression compared with muscle cells transfected with scrambled siRNA (Fig. 6) . Transfection with CAV-3 siRNA blocked the downregulation of Gi3 proteins and upregulation of Gs proteins induced by 6-h treatment with P4 (10 Ϫ5 ) in human ( Fig. 6A ) and guinea pig (Fig. 6B ) gallbladders.
Fig. 2. Effect of GTP-␦S (10
Ϫ7 M) (a direct G protein activator) on muscle cells from human gallbladders with pigment stones and from guinea pig gallbladders (A). The GTP-␦S-induced contraction was only reduced after treatment with P4 (10 Ϫ5 M) alone or P4 after Ch-free liposomes (*P Ͻ 0.01, #P Ͻ 0.01). Ch-rich liposome treatment by itself had no effect and prevented the inhibitory action of P4. The GTP-␦S (10 Ϫ7 M)-induced contraction of muscle cells from human gallbladders with cholesterol stones (ChS; B) was reduced after P4 (10 Ϫ5 M) only after muscle cells were treated with Ch-free liposomes (&P Ͻ 0.01). Values are means Ϯ SE of 3 gallbladders. Fig. 3 . A: effect of Ch-rich liposomes (L) or P4 (10 Ϫ5 M) on the expression of Gi3 proteins in muscle cells from human gallbladder. Ch-rich or Ch-free liposomes had no effect on Gi3 protein expression. However, P4 alone or after treatment with Ch-free liposomes downregulated the expression of this protein (*P Ͻ 0.001). Pretreatment of these muscle cells with Ch-rich liposomes blocked the P4 effect. B: effect of Ch-rich liposomes on P4-induced upregulation of Gs protein expression in muscle cells from human gallbladders with pigment stones. Ch-free and -rich liposomes had no effect on the expression of Gs protein. However, Ch-rich liposome treatment blocked the expected upregulation of Gs protein induced by P4. There were no differences in the Gs protein expression between controls (buffer, Ch-free liposomes, or Ch rich liposomes) and Ch-rich liposomes plus P4 treatment. There were significant differences between Ch-free liposomes and Ch-free liposomes plus P4 (*P Ͻ 0.001) or P4 alone compared with Ch-rich liposomes plus P4 (#P Ͻ 0.001). Optical density (OD) values are means Ϯ SE of 3 gallbladders.
Effects of CAV-3 Ab and siRNA on Ch incorporation by the plasma membrane.
We next examined the interaction of Ch and CAV-3 proteins by directly measuring the effect of CAV-3 Ab and CAV-3 siRNA on caveolar levels of Ch. Pretreatment of muscle cells with CAV-3 Ab had no effect on basal Ch levels in plasma membranes from muscle cells from human gallbladder. However, CAV-3 Ab partially blocked the increase in Ch levels in muscle cells incubated with Ch-rich liposomes for 90 min (Fig. 7A) . These findings suggest that the Ab does not displace bound Ch from CAV-3 proteins but prevents further binding of Ch by the caveolar protein.
This interaction was further studied by examining the effects of CAV-3 siRNA on the Ch content in caveolae of muscle cells from human gallbladders. CAV-3 siRNA reduced the basal Ch levels compared with treatment with scrambled siRNA (Fig. 7B) ; it also lowered the Ch influx from Ch-rich liposomes compared with scramble siRNA plus Ch-rich liposomes. It is thus likely that CAV-3 siRNA may reduce Ch levels by blocking the synthesis of CAV-3 proteins as shown in Fig. 7C . 3 H-P4 into caveolae. We next measured the incorporation of 3 H-P4 into the bulk plasma membrane and caveolar domains of muscle cells pretreated with buffer and Ch-free and Ch-rich liposomes for 90 min. Muscle cells were incubated with 3 H-P4, and the radioactivity levels were measured in caveolae and bulk plasma membranes at 10, 30, and 60 min. In control muscle cells, most of the radioactive P4 was found in the caveolar domains, and its incorporation peaked at 30 min (Fig. 8A) . Treatment of normal muscle cells with Ch-rich liposome for 90 min blocked the entry of 3 H-P4 into the caveolae compared with controls incubated with buffer or Ch-free liposomes. Similar findings were observed when 3 H-P4 was measured in muscle cells pretreated with CAV-3 Ab. The Ab blocked the incorporation of 3 H-P4 into the caveolae of normal muscle cells (Fig. 8B) .
Effects of high levels of plasma membrane Ch in the incorporation of

Effect of GDP-␤S (G protein antagonist) on P4-induced changes in the levels of G proteins.
Since the mechanisms of transport of P4 across the plasma membrane have not been elucidated, we examined the possibility that high levels of Ch blocks the actions of P4 by increasing the levels CAV-3 proteins that are known to sequester ligand receptor-G protein complexes in the caveolae (8, 29) . We assumed that these putative membrane receptors behaved like the majority of plasma membrane receptors that couple to G proteins before they translocate to the caveolae. We therefore examined the effects of the G protein blocker GDP-␤S on P4 actions on G proteins expression. GDP-␤S (10 Ϫ7 M) failed to block the expected Gi3 and Gs protein changes induced by P4 alone (10 Ϫ5 M). P4 downregulated Gi3 expression and upregulated Gs protein expression alone or after treatment with GDP-␤S, suggesting that P4 translocation across the caveolae does not utilize G proteins.
DISCUSSION
In agreement with previous reports, the present studies show that P4 impairs the contraction induced by agonists such as CCK-8 that act on G protein-coupled receptors and GTP-␥S that stimulates G proteins directly. P4 also altered the patterns of expression of G proteins in normal muscle cells downregulating G proteins that mediate contraction (Gi3 proteins) and upregulating G proteins that mediate relaxation (Gs proteins) (6, 28) . Moreover, high concentrations of caveolar Ch blocked the genomic effects of P4 that blocks the GTP-␦S-induced contraction and its effects on G protein patterns. P4 a is steroid hormone with a molecular structure similar to that of Ch, and, therefore, it may compete with P4 for pathways that mediate its genomic effects.
The influx and efflux of Ch through the plasma membrane take place through caveolar domains by interacting with caveolar proteins (11, 16) , particularly with CAV-3 that constitutes the main CAV protein in gallbladder muscle cells and is specific to smooth muscle cells (29) . Furthermore, there is a close interaction between Ch and CAV proteins. Increased Ch influx into caveolar domains increases the concentrations of CAV proteins in guinea pig and human gallbladder muscle cells (29) and other cells because of increased transfer of CAV proteins from the Golgi apparatus and by stimulating their synthesis through increased CAV protein mRNA (11) . We have also shown that increased Ch influx into caveolae inhibits CAV-3 protein phosphorylation, blocking its transfer to early endosomes (8) .
The present studies also show that Ch and P4 appear to interact within the caveolar domains most likely at CAV-3 protein sites. A specific CAV-3 protein Ab blocked the actions of P4 since it prevented the P4-induced inhibition of contraction elicited by GTP-␦S and alterations in G protein patterns. The CAV-3 Ab also inhibited the influx of Ch from Ch-rich liposomes into caveolar domains of muscle cells. These findings were supported in muscle cells transfected with CAV-3 siRNA (8). Treatment with this siRNA for 24 h lowered the CAV-3 expression, reduced caveolar incorporation of Ch from Ch-rich liposomes, and blocked the genomic actions of P4 on G protein patterns. Thus it appears that the genomic actions of P4 require normal concentrations of functionally active CAV-3 proteins. Moreover, high caveolar Ch levels and CAV-3 antibodies blocked the entry of radio-labeled P4 into the caveolar and bulk plasma membrane domains. In control muscle cells, most of the radio-labeled P4 was found in caveolae at 10, 30, and 60 min. Pretreatment with Ch-rich liposomes or with CAV-3 Ab caused a marked reduction in the incorporation of radio-labeled P4 into the caveolae. These findings suggest that the influx of P4, like that of Ch, occurs through caveolae and requires access to CAV-3 sites to be transported into the cell and then by chaperones to its nuclear receptors.
The influx of P4 into muscle cells is controversial. Two studies have suggested that, in addition to the nuclear P4 receptors A and B, there are two P4 receptors in the plasma membrane of myometrial cells that couple to Gi proteins and inhibit the formation of cAMP (4, 9) . These studies demonstrated the presence of these plasma membrane receptors with polyclonal antibodies. A large number of plasma membrane receptors couple to G proteins before they internalize through caveolar domains. These receptors require normal levels of functional CAV proteins to be transferred to endosomes and recycled back to the plasma membrane (8) . Abnormal caveolar levels of Ch disrupt this normal trafficking by sequestering ligand receptor-G protein complexes in caveolae, disrupting their normal recycling and resulting in impaired ligand binding and contraction (29) . In contrast, the present studies showed that high Ch levels and CAV-3 Abs blocked the influx of 3 H-P4 into caveolae. They prevent the influx of P4 into the caveolae possibly because these proteins are already saturated with Ch. It is also possible that the CAV-3 Ab prevents the influx of 3 H-P4 into the caveolae by mechanisms similar to those that block the influx of Ch into the caveolae. Moreover, the finding that GDP-␤S, a G protein blocker, failed to inhibit the genomic actions of P4 is additional evidence that P4 is unlikely to utilize plasma membrane receptors as it is internalized and transported to its nuclear receptors.
In summary, the present studies suggest that P4 is transported across the plasma membrane through caveolar domains, requiring normal levels of functioning CAV-3 levels. High levels of Ch in the caveolae of gallbladder muscle cells similar to those associated with lithogenic bile, which frequently occur in obesity and are induced by the rise of estrogen levels during pregnancy, blocked the effects of P4 on gallbladder muscle cells. In view of these findings, P4 may not play a major role in the pathogenesis of gallbladder hypomotility and disease that is prevalent in pregnancy. They suggest that a normal body mass index before and normal weight gain during pregnancy Fig. 7 . Effect of CAV-3 antibody and CAV-3 siRNA on Ch levels in caveolae from muscle cells from human gallbladders. A: muscle cells were treated with CAV-3 antibody followed by incubation with Ch-free or Ch-rich liposomes for 90 min. The antibody had no effect on basal levels but blocked the Ch influx from Ch-rich liposomes to caveolae (*P Ͻ 0.01 compares Ch-rich vs. CAV-3 Ab plus Ch-rich liposomes). B: CAV-3 siRNA reduced basal Ch levels (*P Ͻ 0.01) and lowered the Ch influx from Ch-rich liposomes compared with scrambled siRNA plus Ch-rich liposomes (#P Ͻ 0.01). Values are means Ϯ SE of 3 specimens. C: Western blot illustrates the expression of CAV-3 protein treated with Ch-rich liposomes after scrambled siRNA and CAV-3 siRNA. CAV-3 siRNA decreased the band densities of CAV-3 proteins in the basal state and after treatment with Ch-rich liposomes. Fig. 8 . Effects of high levels of caveolar Ch and CAV-3 antibody on the incorporation of 3 H-P4 over a 60-min period.
3 H-P4 was determined at 10, 30, and 60 min after the muscle cells were exposed to the radio-labeled hormone. Most of the 3 H-P4 was found in the caveolae, and its incorporation peaked at 30 min. A: muscle cells were pretreated with buffer or Ch-free and Ch-rich liposomes for 90 min. Ch-rich liposome treatment blocked the entry of 3 H-P4 into the caveolae compared with buffer and Ch-free liposomes (*P Ͻ 0.01). B: likewise, CAV-3 Ab blocked the entry of 3 H-P4 into the caveolae compared with buffer (#P Ͻ 0.01). Values are means Ϯ SE of 3 human gallbladders.
